线粒体核糖体蛋白L12通过调节线粒体生物发生和代谢重编程来强化肝细胞癌
Xingzhao Ji1, Zhen Yang2, Chensheng Li3
1Department of Pulmonary and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, China; Shandong Key Laboratory of Infections Respiratory Disease, Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
线粒体核糖体蛋白L12 (MRPL12) 通过改变线粒体代谢,驱动肝细胞癌 (HCC) 的进展. 准MRPL12为HCC治疗提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 线粒体生物学 线粒体生物学
- 癌症的分子机制
背景情况:
- 肝细胞癌 (HCC) 的特点是线粒体功能障碍和代谢重编程.
- 线粒体核糖体蛋白L12 (MRPL12) 在HCC瘤发生中的作用在很大程度上仍未被探索.
- MRPL12是一种新发现的基因,参与线粒体转录调节和新陈代谢.
研究的目的:
- 研究MRPL12在肝细胞癌 (HCC) 发展和进展中的作用.
- 阐明MRPL12在HCC中的功能背后的分子机制.
- 探索MRPL12作为HCC的潜在治疗点.
主要方法:
- 通过在线数据库,西部抹杀,qRT-PCR和IHC评估了HC中的MRPL12表达.
- 相关的MRPL12表达与临床病理特征和通过组织微阵列的预后.
- 利用体内异种移植模型,基因淘汰/过度表达,ChIP,海马XF96和细胞功能测试来确定生物功能和机制.
主要成果:
- 在HCC组织和细胞系中,MRPL12显著上调,与晚期,更高等级和不良预后相关.
- 过度表达MRPL12促进了HCC细胞的增殖,迁移,入侵和瘤性,而敲击抑制了这些效应.
- MRPL12调节线粒体平衡,影响氧化酸化 (OXPHOS) 和线粒体DNA含量;PI3K/mTOR/YY1通路调节MRPL12的表达.
结论:
- 通过调节线粒体新陈代谢,MRPL12驱动HCC恶性病变.
- 在HCC中异常的MRPL12表达是由PI3K/mTOR/YY1通路控制的.
- 针对MRPL12是一个有前途的治疗策略,用于HCC.
更多相关视频
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
08:39Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides
Published on: September 16, 2020
相关概念视频
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Mitochondria
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Abnormal Proliferation
